Found: 5
Select item for more details and to access through your institution.
Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study.
- Published in:
- BJU International, 2022, v. 129, n. 1, p. 32, doi. 10.1111/bju.15589
- By:
- Publication type:
- Article
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification.
- Published in:
- BJU International, 2019, v. 124, n. 3, p. 532, doi. 10.1111/bju.14808
- By:
- Publication type:
- Article
Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 10, p. e2337494, doi. 10.1001/jamanetworkopen.2023.37494
- By:
- Publication type:
- Article
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 63, doi. 10.1111/bjh.17073
- By:
- Publication type:
- Article
The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article